The protective effect of catalpol on diabetic osteoporosis (DOP) and its mechanism remain unclear. This study aimed to explore whether catalpol enhanced the proliferation and differentiation of MC3T3 cells induced by high glucose by inhibiting the expression of KDM7A. Methods: MC3T3 cells were induced by high glucose (HG) and treated with different concentrations of catalpol. The proliferation and mineralization abilities of MC3T3-E1 cells were determined by CCK-8 assay and Alizarin Red Staining, respectively. The expression of differentiation-related osteogenic proteins, KDM7A and related proteins of Wnt/β-catenin signaling pathway was analyzed by Western blot analysis. The alkaline phosphatase (ALP) activity was detected by ALP assay kits. Results: MC3T3-E1 cells induced by high glucose showed decreased proliferation and mineralization abilities and decreased ALP activity, which were all reversed by the treatment of catalpol. High glucose induction inhibited the expression of KDM7A, Total-β-catenin, Nuclear-β-catenin and p-GSK3β, which was reversed by the treatment of catalpol. And KDM7A interference up-regulated the expression of Total-β-catenin, Nuclear-β-catenin and p-GSK3β, which was down-regulated by KDM7A overexpression. Furthermore, the proliferation and mineralization abilities and ALP activity were improved when treated with KDM7A interference and decreased when treated with KDM7A overexpression. However, SKL2001 could improve the proliferation and mineralization abilities and ALP activity of MC3T3-E1 cells. Discussion: Catalpol promotes the proliferation and differentiation of osteoblasts induced by high glucose by regulating the Wnt/β-catenin signaling pathway through KDM7A.
Introduction
Diabetes mellitus (DM) is a chronic metabolic syndrome characterized by hyperglycemia. In the world, high incidence of DM seriously threatens public health in the 21st century. 1 Diabetes is a disease of the endocrine system, which can cause complications of the eyes, nerves, feet, kidneys, nervous system, heart and skeleton, which has brought a great blow to DM patients and their families. 2 With osteoporosis as the main manifestation of DM, diabetic osteoporosis (DOP) is a metabolic bone disease with high incidence belonging to DM complications. Diabetic patients are affected by factors such as abnormal insulin and obesity. The lack of insulin will cause the imbalance of bone resorption and bone formation, which will further aggravate osteoporosis. 3, 4 Due to unclear pathogenesis of DOP, the treatment effect of it is not ideal. Therefore, it is urgent to find an effective method to alleviate the osteoporosis of DM patients.
Catalpol is a kind of active ingredient mainly composed of iridoid, and it is extracted from the roots of Rehmannia glutinosa. Traditional Chinese medicine (TCM) has long been used to treat DM, osteoporosis, and cardiovascular disease in China. 5 Catalpol has been widely studied in DM complications. Zou et al 6 indicated that catalpol could mitigate myocardial damage and exert cardioprotective effect against diabetic cardiomyopathy. Studies have shown that catalpol could improve neointimal hyperplasia in hyperglycemic rats. 7, 8 And, catalpol could reduce the injury of diabetic atherosclerosis. 9 Furthermore, the bone healing capacity of bone marrow mesenchymal stem cells (BMSCs) was improved by the catalpol treatment through promoting the BMSC proliferation and osteogenic differentiation. 10, 11 However, the role of catalpol in diabetes-induced osteoporosis has not been studied. Recent studies have shown that KDM7A interference can promote BMSCs to differentiate into osteoblasts by activating the Wnt/β-catenin signaling pathway. 12 In this study, we constructed the model of osteoblast MC3T3-E1 cells induced by high glucose. This study was designed to explore whether catalpol could regulate the proliferation and differentiation of MC3T3 cells induced by high glucose through activating the Wnt/β-catenin signaling pathway through KDM7A.
Materials and Methods
Cell Culture and Cell Induction MC3T3-E1 cells were purchased from American Type Culture Collection (ATCC ® CRL-2594; Rockville, MD, USA). MC3T3-E1 cells were placed in α-MEM medium containing 10% fetal bovine serum (FBS), 100 IU/mL penicillin and 100 μg/mL streptomycin and cultured at 37°C with 5% CO 2 under saturated humidity. The medium was replaced every 2-3 days, and MC3T3-E1 cells had digestive transfer culture with 0.25% trypsin after fusion growth. MC3T3-E1 cells were induced by high glucose (HG) for 14 d and treated with different concentrations of catalpol (Purity 98%, Chengdu Dast Biotechnology Co., Ltd) (1mg/mL, 2mg/mL and 4mg/mL). MC3T3-E1 cells were treated with mannitol in HM group while received no treatment in the control group. Mannitol was used as a control group of osmotic pressure.
Cell Transfection
After induction of high glucose for 14 d, MC3T3-E1 cells were, respectively, transfected with shRNA-NC, shRNA-KDM7A-1, shRNA-KDM7A-2, overexpression-NC and overexpression-KDM7A using Lipofectamine ® 2000 reagent (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). The transfection efficiency was determined by Western blot analysis. Moreover, HG-induced MC3T3-E1 cells transfected with overexpression-KDM7A were also treated with SKL2001 (Wnt/β-catenin agonist).
CCK-8 Assay
MC3T3-E1 cells were inoculated into a 96-well plate (100 micron) at the density of 5×10 3 cells per well. The holes around the inoculated cells were added with sterile PBS, and they were considered as the blank control. After the high glucose induction and catalpa treatment, 10μL CCK-8 reagent was added to each hole and incubated in the incubator for 3 h under dark conditions. The 96-well plate was put into the enzyme-linked immunometric meter, and the absorbance (OD value) of each well was measured at the wavelength of 450 nm.
Alizarin Red Staining
MC3T3-E1 cells were induced with high glucose for 14 d and treated with catalpa (1mg/mL, 2mg/mL and 4mg/mL). After the culture, MC3T3-E1 cells were washed with precooled PBS, fixed with 70% alcohol for 20min, and the fixative solution was discarded. The cell samples were washed with PBS twice, and 500μL 0.1% alizarin red dye was added to cover the MC3T3-E1 cells for staining for 5 min. Finally, the staining solution was absorbed and washed with PBS twice. The formation of stained calcified nodules was observed under an inverted phase-contrast microscope.
Western Blot Analysis
After the induction of high glucose and treatment of catalpa, proteins in MC3T3-E1 cells were extracted with RIPA lysis buffer (Beyotime, China) and protein concentration was determined by Bradford method. Each hole was loaded with 30μg protein, separated with the SDS-PAGE gel for electrophoresis and transferred to nitrocellulose membranes. The 5% skim milk solution was prepared with the solvent of PBST, which was used to seal the nitrocellulose membranes at room temperature for 2h. Then, primary antibodies including RUNX2 (ab192256;Abcam), Collagen I (ab34710;Abcam), OCN (ab13420;Abcam), BMP4 (ab39973;Abcam), BMP7 (ab56023;Abcam), KDM7A (A14692;ABclonal), β-catenin (ab16051;Abcam), pGSK3β (ab75745;Abcam), GSK3β (ab32391;Abcam), histone (ab1220;Abcam) and GAPDH (ab9485;Abcam) (dilution,1:1000) were incubated with nitrocellulose membranes at 4°C for 12h. PBST was used to wash the nitrocellulose membranes 3 times with 10 min/time. HRP-labeled secondary antibody was incubated with the nitrocellulose membranes at room temperature for 1h. After the nitrocellulose membranes were fully washed, they were then treated with ECL chemiluminescent solution from Millipore. The Bio-Rad gel imaging analysis system was used to collect and analyze the bands.
Alkaline Phosphatase (ALP) Activity
MC3T3-E1 cells were induced by high glucose for 14 d and treated with catalpa. After 72 h, PBS solution was added to each hole to wash the plates for 3 times. 0.2% Triton X-100 (100μL) was added to each hole, and the MC3T3-E1 cells were oscillated with an ultrasonic cell disruptor. The cell lysates were collected after centrifugation and stored at −70°C. Total protein concentration was measured with the BCA kits. The ALP content was measured with the ALP assay kit, and the relative ALP activity was calculated finally.
Statistical Analysis
The experimental data presented as mean ± standard deviation were processed and analyzed by SPSS 22.0. The statistical method was one-way analysis of variance with Tukey's post hoc test, which was used to compare the differences among multiple groups. The differences have statistical significance when P<0.05.
Results

Catalpol Alleviates the Inhibition Effects of HG on Proliferation of MC3T3-E1 Cells
The CCK-8 assay was used to detect the cell proliferation of MC3T3-E1 cells disposed by HG and catalpol ( Figure 1 ). The proliferation of MC3T3-E1 cells treated with mannitol was not statistically changed compared with the control group, while the proliferation of MC3T3-E1 cells was obviously decreased when cells were disposed by HG. With the increasing catalpol dosages, the proliferation of HG-induced MC3T3-E1 cells was gradually improved.
Catalpol Alleviates the Inhibition Effects of HG on Differentiation of MC3T3-E1 Cells
As shown in Figure 2A , there is no statistical difference in calcium nodules between control group and HM group. The calcium nodules were decreased in HGinduced MC3T3-E1 cells while the formation of mineralized nodules was increased when HG-induced MC3T3-E1 cells were treated with the increase of catalpol. The expression of cell differentiation-related proteins was analyzed by Western blot ( Figure 2B ). The expression of RUNX2, Collagen I, OCN, BMP4 and BMP7 in HG-induced MC3T3-E1 cells was obviously decreased compared with the control group and HM group. However, catalpol treatment promoted the expression of RUNX2, Collagen I, OCN, BMP4 and BMP7 in HG-induced MC3T3-E1 cells and the promotion role of catalpol in the expression of these proteins was enhanced with the increase of catalpol. The ALP activity in the control group was not statistically different from the HM group. HG significantly inhibited the ALP activity in MC3T3-E1 cells and the ALP activity in HG-induced MC3T3-E1 cells was gradually increased when the concentration of catalpol was increased ( Figure 2C ). catalpol promoted the expression of Total-β-catenin, Nuclear-β-catenin and p-GSK3β in a dose-dependent manner. The expression of GSK3β and histone in all groups was not changed ( Figure 3B ).
Catalpol Regulates the Wnt/β-Catenin
Signaling Pathway Through KDM7A in MC3T3-E1 Cells Induced by HG Cell transfection confirmed by Western blot analysis showed that the expression of KDM7A was down-regulated in MC3T3-E1 cells transfected with ShRNA-KDM7A-1 and ShRNA-KDM7A-2, and it was up-regulated in MC3T3-E1 cells transfected with overexpression-KDM7A. The KDM7A expression in ShRNA-KDM7A-1-transfected MC3T3-E1 cells was lower than that in ShRNA-KDM7A-2-transfected MC3T3-E1 cells, so ShRNA-KDM7A-1 was used in the subsequent experiment ( Figure 4A ). HG decreased the expression of Total-β-catenin, Nuclear-β-catenin and p-GSK3β, and 4mg/kg catalpol reversed the HG inhibition against the expression of Total-β-catenin, Nuclear-β-catenin and p-GSK3β. The expression of Total-β-catenin, Nuclear-β-catenin and p-GSK3β in HGinduced MC3T3-E1 cells treated with 4mg/kg catalpol was promoted by silencing of KDM7A and KDM7A overexpression ( Figure 4B ). SKL2001 is used as a β-catenin agonist. HG induction inhibited cell proliferation, while 4mg/kg catalpol improved the proliferation of HG-induced MC3T3-E1 cells. Silencing of KDM7A could further improve the proliferation ability of HG-induced MC3T3-E1 cells treated with 4mg/kg catalpol. KDM7A overexpression inhibited the proliferation of HG-induced MC3T3-E1 cells treated with 4mg/kg catalpol compared with HG+4mg/ mL group while SKL2001 improved the proliferation of HG-induced MC3T3-E1 cells ( Figure 5A ). HG induction decreased the mineralized nodules and 4mg/kg catalpol increased the mineralized nodules in HG-induced MC3T3-E1 cells. The mineralized nodules in HGinduced MC3T3-E1 cells treated with 4mg/kg catalpol continued to increase when they were transfected with ShRNA-KDM7A while decreased when they were transfected with overexpression-KDM7A. And, SKL2001 further increased the mineralized nodules in HG-induced MC3T3-E1 cells ( Figure 5B ). The expression of RUNX2, Collagen I, OCN, BMP4 and BMP7 in MC3T3-E1 cells was decreased when induced by HG while increased when treated with 4mg/kg catalpol. Silencing of KDM7A enhanced the expression of RUNX2, Collagen I, OCN, BMP4 and BMP7 in HG-induced MC3T3-E1 cells treated with 4mg/kg catalpol. KDM7A overexpression suppressed the expression of these proteins while SKL2001 could reverse this effect ( Figure 5C ). HG significantly decreased the ALP activity in MC3T3-E1 cells, which was reversed by the treatment of 4mg/kg catalpol. Silencing of KDM7A further improved the ALP activity of HG-induced MC3T3-E1 cells treated with 4mg/kg catalpol. KDM7A overexpression inhibited the ALP activity while SKL2001 improved the ALP activity of HG-induced MC3T3-E1 cells ( Figure 5D ).
Discussion
Here, we explored whether catalpol enhanced the proliferation and differentiation of MC3T3 cells induced by high glucose through Wnt/β-catenin signaling pathway through KDM7A. It was shown that catalpol promoted the proliferation and differentiation by activating the Wnt/β-catenin signaling pathway through suppressing the KDM7A expression.
KDM7A, also known as JHDM1D, contains a JmjC domain which can remove the enzyme activity of histone methylation markers. [13] [14] [15] [16] KDM7A promotes the development of nerve and brain by removing dimethylated markers of H3K9me2 and H3K27me2 in the FGF4 promoter regions. 17 In the hunger state, the up-regulated expression of KDM7A can inhibit the expression of angiogenic factors, thereby inhibiting the formation of blood vessels and tumor growth. 18 Son et al 19 found that KDM7A was involved in the differentiation of brown fat cells. Research has shown that mRNA expression of KDM7A is up-regulated during the adipogenic differentiation of ST2 cells. Overexpression of KDM7A wild type plasmid may promote the differentiation of ST2 cells into adipocytes and inhibit the differentiation of ST2 cells into osteoblasts. 20 In this study, HG promoted the expression of KDM7A while catalpol inhibited the expression of KDM7A. And, the differentiation of MC3T3-E1 cells was inhibited in HG-induced MC3T3-E1 cells, which could be reversed by catalpol treatment. Silencing of KDM7A in HG-induced MC3T3-E1 cells treated with catalpol could further enhance the differentiation of MC3T3-E1 cells, which was reversed by KDM7A overexpression. Hence, KDM7A inhibition plays a positive role in promoting KDM7A expression, which is consistent with the published article.
As an important transcription factor in osteoblastic differentiation, Runx2 is involved in osteoblastic and chondrogenic differentiation. Its expression is regulated by the Wnt and BMP signaling pathways. 21 However, contrary to the role in regulating osteoblastic differentiation as an early transcription factor, Runx2 may inhibit osteoblastic differentiation in late differentiation. 22 Here, Runx2 expression was increased when the differentiation of MC3T3-E1 cells was increased. Activation of Wnt/βcatenin signaling pathway can promote osteoblast differentiation and proliferation. 23 In precursor osteoblasts, deficiency of β-catenin causes the development of osteoblast stagnating at an early stage, thereby leading to defective embryonic skeletal. 24 In developing osteoblasts, lack of β-catenin leads to impaired differentiation and mineralization. 25 The Wnt/β-catenin signaling pathway can alter the ratio of OPG/RANKL in mature and precursor osteoblasts, thereby reducing bone absorption. 26 Here, Wnt/β-catenin expression was activated by SKL2001. KDM7A overexpression inhibited the differentiation of HG-induced MC3T3-E1 cells treated with catalpol, which could be promoted by SKL2001.
In conclusion, catalpol improved the proliferation and differentiation of MC3T3 cells induced by HG by activating the Wnt/β-catenin signaling pathway by inhibiting the expression of KDM7A. The new findings may provide theoretical instructions for DOP clinically. The ALP activity in HG-induced MC3T3-E1 cells after transfection was assessed by the ALP assay kit. *P<0.05 and ***P<0.001 vs. control group. # P<0.05 and ### P<0.001 vs. HG group. Δ P<0.05, vs. HG+4mg/mL group.
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